SCHEMBL18535196

SCHEMBL18535196

N=C(C(=O)O)C1=C(N)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2209103 0.77 — —
SCHEMBL4023693 0.72 TSHR (0.32) —
SCHEMBL18757668 0.72 — —
SCHEMBL10123519 0.72 TSHR (0.32) —
SCHEMBL18757666 0.70 — —
SCHEMBL18810117 0.70 — —
SCHEMBL11406762 0.67 — —
SCHEMBL8283993 0.67 — —
SCHEMBL15386621 0.67 — —
SCHEMBL11406937 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081381-A1 NOVEL ARYLALKYL PYRAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-04-23 — — WO disclosed
EP-2763990-B1 PYRROLOPYRAZINE KINASE INHIBITORS HOFFMANN LA ROCHE (CH) 2017-02-22 — — EP disclosed
Send feedback